Iron Overload Related to Excessive Vitamin C Intake [5]

Annals of Internal Medicine

Volumn 139, Issue 6, 2003, Pages 532-533

  Mallory, Mark A ^a   Sthapanachai, Chalengpoj ^a   Kowdley, Kris V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; IRON; FERROUS ION; FERROUS SULFATE;

ADULT; CASE REPORT; FATIGUE; FEMALE; HUMAN; IRON OVERLOAD; IRON STORAGE; IRON THERAPY; LETTER; LIVER BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; DIET SUPPLEMENTATION; MIDDLE AGED; SELF MEDICATION;

ASCORBIC ACID; DIETARY SUPPLEMENTS; FEMALE; FERROUS COMPOUNDS; HUMANS; IRON OVERLOAD; MIDDLE AGED; SELF MEDICATION;

EID: 0141797416     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-6-200309160-00032     Document Type: Letter

References (8)

1. Britton RS, Fleming RE, Parkkila S, Waheed A, Sly WS, Bacon BR. Pathogenesis of hereditary hemochromatosis: genetics and beyond. Semin Gastrointest Dis. 2002;13:68-79. [PMID: 12064862]
2. , Cook JD, Watson SS, Simpson KM, Lipschitz DA, Skikne BS. The effect of high ascorbic acid supplementation on body iron stores. Blood. 1984;64:721-6. [PMID: 6466873]
3. Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron absorption by women with low iron stores. Am J Clin Nutr. 1994;59:1381-5. [PMID: 8198064]
4. Hoffman KE, Yanelli K, Bridges KR. Ascorbic acid and iron metabolism: alterations in lysosomal function. Am J Clin Nutr. 1991;54:1188S-1192S. [PMID: 1962568]
5. Toth I, Rogers JT, McPhee JA, Elliott SM, Abramson SL, Bridges KR. Ascorbic acid enhances iron-induced ferritin translation in human leukemia and hepatoma cells. J Biol Chem. 1995;270:2846-52. [PMID: 7852359]
6. Pointon JJ, Wallace D, Merryweather-Clarke AT, Robson KJ. Uncommon mutations and polymorphisms in the hemochromatosis gene. Genet Test. 2000;4:151-61. [PMID: 10953955]
7. Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood. 2001;97:2555-60. [PMID: 11313241]
8. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest. 2001;108:619-23. [PMID: 11518736]